Document:

<PAGE>

                                                                  EXHIBIT 10(mm)

                            CENTERPOINT ENERGY, INC.
                  SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION

         The following is a summary of compensation paid to the non-employee
directors of CenterPoint Energy, Inc. (the "Company") effective June 2, 2005.
For additional information regarding the compensation of the non-employee
directors, please read the definitive proxy statement relating to the Company's
2006 annual meeting of shareholders to be filed pursuant to Regulation 14A.

     o   Annual retainer fee of $50,000 for Board membership;

     o   Fee of $1,500 for each Board meeting attended;

     o   Fee of $2,000 for each Audit Committee meeting attended;

     o   Fee of $1,500 for each meeting of any other Board committee attended;

     o   Supplemental annual retainer of $10,000 for serving as a chairman of
         the Audit Committee; and

     o   Supplemental annual retainer of $5,000 for serving as a chairman of any
         other Board committee.

      The Chairman receives the compensation payable to other non-employee
directors plus supplemental compensation pursuant to a letter agreement with the
Company incorporated by reference to Exhibit 10(w) to the Company's Annual
Report on Form 10-K for the year ended December 31, 2005.

      Stock Grants. Each non-employee director also receives an annual grant of
up to 5,000 shares of CenterPoint Energy common stock which vest in one-third
increments on the first, second and third anniversaries of the grant date. Upon
the initial nomination to the Board, in addition to the annual grant, a
non-employee director may be granted a one-time grant of up to but not exceeding
5,000 shares of CenterPoint Energy common stock.

      Deferred Compensation Plan. Directors may elect each year to defer all or
part of their annual retainer fees and meeting fees. Directors participating in
these plans may elect to receive distributions of their deferred compensation
and interest in three ways: (i) an early distribution of either 50% or 100% of
their account balance in any year that is at least four years from the year of
deferral up to the year in which they reach age 70, (ii) a lump sum distribution
payable in the year after they reach age 70 or upon leaving the Board of
Directors, whichever is later, or (iii) 15 annual installments beginning on the
first of the month coincident with or next following age 70 or upon leaving the
Board of Directors, whichever is later.

      Director Benefits Plan. Non-employee directors elected to the Board before
2004 participate in a director benefits plan under which a director who serves
at least one full year will receive an annual cash amount equal to the annual
retainer (excluding any supplemental retainer) in effect when the director
terminates service. Benefits under this plan begin the January following the
later of the director's termination of service or attainment of age 65, for a
period equal to the number of full years of service of the director.

      Executive Life Insurance Plan. Non-employee directors who were elected to
the Board before 2001 participate in CenterPoint Energy's executive life
insurance plan. This plan provides endorsement split-dollar life insurance with
a death benefit equal to six times the director's annual retainer, excluding any
supplemental retainer, with coverage continuing after the director's termination
of service at age 65 or later. Directors elected to the Board after 2000 may not
participate in this plan.<PAGE>
                                                                  EXHIBIT 10(nn)

                            CENTERPOINT ENERGY, INC.
                 SUMMARY OF NAMED EXECUTIVE OFFICER COMPENSATION

         The following is a summary of compensation paid to the named executive
officers of CenterPoint Energy, Inc. (the "Company"). For additional information
regarding the compensation of the named executive officers, please read the
definitive proxy statement relating to the Company's 2006 annual meeting of
shareholders to be filed pursuant to Regulation 14A and the Company's Current
Report on Form 8-K referenced below.

         Base Salary. The following table sets forth the annual base salary of
the Company's named executive officers effective April 1, 2006:

<Table>
<Caption>
                    NAME AND POSITION                     2006 BASE SALARY
                    -----------------                     ----------------
<S>                                                           <C>
       David M. McClanahan                                    $980,000
       President and Chief Executive Officer

       Gary L. Whitlock                                       $445,000
       Executive Vice President and Chief
       Financial Officer

       Scott E. Rozzell                                       $425,000
       Executive Vice President, General
       Counsel and Corporate Secretary

       Thomas R. Standish                                     $405,000
       Senior Vice President and Group
       President - Regulated Operations

       Byron R. Kelley                                        $313,000
       Senior Vice President and Group
       President and Chief Operating Officer,
       CenterPoint Energy Pipelines and
       Field Services
</Table>

         Short-Term Incentive Compensation Plan. Annual bonuses are paid to the
Company's named executive officers pursuant to the Company's short-term
incentive compensation plan, which provides for cash bonuses based on the
achievement of certain performance objectives approved in accordance with the
terms of the plan at the commencement of the year. Information regarding
performance goals for the named executive officers for 2006 is contained in the
Company's Current Report on Form 8-K dated February 22, 2006.

         Long-Term Incentive Compensation. Under the Company's long-term
incentive plan, the Company's named executive officers may receive grants of (i)
stock option awards, (ii) performance share awards, (iii) performance unit
awards and/or (iv) stock awards. Information regarding the terms of certain
grants pursuant to the Company's long-term incentive plan is contained in the
Company's Current Report on Form 8-K dated February 22, 2006.exv10w03

 

Exhibit 10.3

FIRST AMENDMENT

TO

PARTNERSHIP INTEREST PURCHASE AGREEMENT

     This First Amendment to Partnership Interest Purchase Agreement (this “First
Amendment”) is made and entered into to be effective as of March 13, 2006 (the “First
Amendment Date”), by and among Del Mar GenPar, Inc., a Nevada corporation (“GenPar”);
Del Mar Acquisition, Inc., a Nevada corporation (“Newco” and, together with GenPar, each
individually a “Buyer” and collectively the “Buyers”); Surgical Ventures, Inc., a
California corporation (the “Seller”); and David M. Kupfer, M.D., an individual residing in
and licensed to practice medicine in the State of California (“Kupfer”).

     WHEREAS, the Buyers, the Seller and Kupfer entered into that certain Partnership Interest
Purchase Agreement, dated as of December 2, 2005 (as amended by this First Amendment, the
“Purchase Agreement”), pursuant to which the Seller agreed to sell, and the Buyers agreed
to purchase, certain equity interests in Elite Surgical Centers, Del Mar L.P., a California limited
partnership (the “Partnership”), on the terms and subject to the conditions set forth
therein;

     WHEREAS,
the Partnership engages in the business of operating the
Point Loma Surgical Center located at 12264 El Camino Real, Suite 55,
San Diego, California 92130;

     WHEREAS, the Buyer, the Seller and Kupfer have determined that it is desirable and in the best
interests of the parties to make certain amendments to the Purchase Agreement as set forth in this
First Amendment, such that instead of the Seller selling to Newco, and Newco purchasing from the
Seller, the entire LP Interest at the Closing, the Seller will instead sell to Newco, and Newco
will purchase from the Seller, (a) at the Initial Closing (as defined below), a limited partnership
interest having a Percentage Interest of 19.99% (the “LP Initial Interest”); and (b) at the
Closing, a limited partnership interest having a Percentage Interest of
31.01% (the “LP Option Interest” and, together with the LP Initial Interest, the “LP
Interest,” and collectively with the LP Initial Interest and the GP Interest, the
“Purchased Interests”), on the terms and subject to the conditions set forth in the
Agreement, as amended by this First Amendment;

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual representations,
warranties, covenants and agreements set forth herein, and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

ARTICLE I

Amendments

     1. Defined Terms; References. All capitalized terms used but not otherwise defined in
this First Amendment have the meanings ascribed to such terms in the Purchase Agreement. Unless
otherwise specified, all article and section references in this First Amendment refer to articles
or sections of the Purchase Agreement.

 

 

     2. Title of Purchase Agreement. The Purchase Agreement and each of the other Seller
Documents and Buyer Documents, and any and all other agreements, documents or instruments now or
hereafter executed and delivered pursuant to the terms hereof or pursuant to the terms of the
Purchase Agreement, as amended hereby (collectively, the “Purchase Documents”), are hereby
amended so that each reference to the Purchase Agreement therein means a reference to the Purchase
Agreement as amended by this First Amendment.

     3. Section 1.1, Purchase and Sale of the Purchased Interests. Section 1.1(b) of the
Purchase Agreement is hereby deleted and the following inserted in lieu thereof:

     “(b) Pursuant to the terms and subject to the conditions set forth herein, Newco hereby
agrees to purchase from the Seller, and the Seller hereby agrees to sell to Newco, the LP
Initial Interest, for the consideration set forth in Section 1.3(b).

     (c) Pursuant to the terms and subject to the conditions set forth herein, Newco hereby
agrees to purchase from the Seller, and the Seller hereby agrees to sell to Newco, the LP
Option Interest, for the consideration set forth in Section 1.3(c).”

     4. Section 1.2, Closing Date. Section 1.2 of the Purchase Agreement is hereby deleted
and the following inserted in lieu thereof:

     “1.2 Closing Dates.

     (a) The consummation of the sale and purchase of the LP Initial Interest (the
“Initial Closing”) will take place at the offices of Tri-Isthmus Group, Inc., a
Delaware corporation formerly known as Vsource, Inc. and indirect parent of the Buyers
(“TISG”), located at 7855 Ivanhoe Avenue, Suite 200, La Jolla, California 92037, at
11:00 a.m. local time on the First Amendment Date. The Initial Closing will be effective as
of 12:01 a.m. on the First Amendment Date.

     (b) The consummation of the sale and purchase of the GP Interest and the LP Option
Interest (the “Closing”) will take place at the offices of TISG at 11:00 a.m. local
time on such date, time and place as is mutually agreed among the parties or, if there is no
agreement among the parties as to another day, on the day that is two business days
following the date on which all conditions to the obligations of the parties set forth in
Article V (other than those conditions to be satisfied at the time of the Closing) have been satisfied or waived (such date being herein called the “Closing
Date”). The Closing will be effective as of 12:01 a.m. on the Closing Date.”

In addition, each of the Purchase Documents is hereby amended so that each reference to “VSCE”
therein is replaced with a reference to TISG.

     5. Section 1.3, Consideration. Section 1.3 of the Purchase Agreement is hereby
amended by:

	 	(a)	 	deleting subsection (b) in its entirety and inserting the following in lieu
thereof:

2

 

“(b) LP Interest.

     (i) As consideration in full for the sale and purchase of the LP Initial
Interest, Newco will pay to the Seller an aggregate of $499,750 (the “LP Initial
Purchase Price”). The LP Initial Purchase Price will be payable at the Initial
Closing by the issuance by Newco to the Seller of the Series B Initial Shares (as
defined below).

     (ii) As consideration in full for the sale and purchase of the LP Option
Interest, Newco will pay to the Seller an aggregate of $750,250 (the “LP Option
Purchase Price”). The LP Option Purchase Price will be payable at the Closing
by the issuance by Newco to the Seller of the Series A LP Shares and the Series B
Option Shares (each as defined below).”;

	 	(b)	 	deleting from subsection (e) thereof the reference to “LP Interest” and
inserting “LP Option Interest” in lieu thereof; and
	 
	 	(c)	 	deleting subsection (g) in its entirety and inserting the following in lieu
thereof:

     “(g) “Series B Initial Shares” means the 9,995 shares of Series B Preferred
Stock that will be issued to the Seller by Newco at the Initial Closing as full
consideration for the sale and purchase of the LP Initial Interest;

     (h) “Series B Option Shares” means the 9,130 shares of Series B Preferred Stock
that will be issued to the Seller by Newco at the Closing as partial consideration for the
sale and purchase of the LP Option Interest.”

     6. Section 1.4, Initial Closing Deliveries. The following new Section 1.4 is hereby
inserted into the Purchase Agreement immediately following Section 1.3:

     “1.4 Initial Closing Deliveries. At the Initial Closing:

     (a) Newco will issue to the Seller the Series B Initial Shares, and will deliver to the
Seller certificates representing the Series B Initial Shares and any other documents that
are necessary to transfer to the Seller good title to the Series B Initial Shares;

     (b) the Seller will execute and deliver to Newco any documents that are necessary to
transfer to Newco good title to the LP Initial Interest, including, without limitation, the
Assignment of LP Initial Interest, substantially in the form of Exhibit F attached
hereto;

     (c) Newco and the Seller will enter into an Agreement of Limited Partnership of Elite
Surgical Centers, Del Mar L.P., dated as of the First Amendment Date, by and between the
Seller, as the general partner, and Newco, as a limited partner, in form and substance
mutually satisfactory to Newco and the Seller (the “Initial LP Agreement”); and

3

 

     (d) Newco will be admitted to the Partnership as a limited partner in accordance with
the relevant provisions of the Initial LP Agreement.”

     7. Section 1.5, Closing Deliveries. The previously existing Section 1.4 of the
Purchase Agreement is hereby renumbered as Section 1.5, and such Section 1.5 is hereby amended by:

	 	(a)	 	deleting from subsection (b) thereof the reference to “Series B Shares” and
inserting “Series B Option Shares” in lieu thereof;
	 
	 	(b)	 	deleting from subsection (c) thereof the references to “LP Interest” and
“Assignment of LP Interest” and inserting “LP Option Interest” and “Assignment of LP
Option Interest,” respectively, in lieu thereof;
	 
	 	(c)	 	deleting from subsection (d) thereof the reference to “Section 12.19” and
inserting “the relevant provisions” in lieu thereof;
	 
	 	(d)	 	deleting subsection (e) in its entirety; and
	 
	 	(e)	 	re-lettering subsections (f), (g) and (h) as subsections (e), (f) and (g),
respectively.

     8. Section 1.6, Further Assurances. The previously existing Section 1.5 of the
Purchase Agreement is hereby re-numbered as Section 1.6.

     9. Section 2.9, Accounts Receivable. The first sentence of Section 2.9 of the
Purchase Agreement is hereby deleted and the following inserted in lieu thereof:

     “2.9 Accounts Receivable. Set forth in Schedule 2.9 is a complete and
accurate schedule of the Non-Litigated Accounts Receivable as of March 8, 2006, excluding
the accounts receivable deposit of March 9, 2006 (collectively and together with all
accounts receivable of the Partnership created after March 8, 2006, the “Accounts
Receivable”); provided, that “Non-Litigated Accounts Receivable” means
all accounts receivable of the Partnership that are not classified as Litigated Accounts
Receivable by Physicians Management Group; further provided, that “Litigated
Accounts Receivable” means all accounts receivable of the Partnership for which
Physicians Management Group pursues legal or quasi-legal action in connection with the
collection of such accounts receivable.”

     10. Section 2.12, Financial Statements. Section 2.12 of the Purchase Agreement is
hereby amended by deleting the references to “November 30, 2005” and “December 31, 2003 and 2004”
and inserting “January 31, 2006” and “December 31, 2003, 2004 and 2005,” respectively, in lieu
thereof.

     11. Section 2.19, Payors. Section 2.19 of the Purchase Agreement is hereby amended by
deleting the reference to “for the interim period ending on the Latest Balance Sheet Date” and
inserting “2005” in lieu thereof.

4

 

     12. Section 2.31, Accredited Investor; Disclosure Materials. Section 2.31 of the
Purchase Agreement is hereby amended by deleting the reference to “and the Series B Shares” and
inserting “, the Series B Initial Shares and the Series B Option Shares” in lieu thereof.

     13. Section 4.1, Conduct of Business. Section 4.1(e) of the Purchase Agreement is
hereby amended by deleting the reference to “the Purchased Interests” and inserting “the GP
Interest and the LP Option Interest” in lieu thereof.

     14. Section 5.1, Conditions to Obligations of the Buyers. Section 5.1 of the Purchase
Agreement is hereby amended by:

     (a)
deleting from subsection (j) thereof the references to “Del Mar
Surgical Center, L.P.” and
“Effective Date” and inserting “Elite Surgical
Centers, Del Mar L.P.” and “Closing Date,”
respectively, in
lieu thereof;

     (b) deleting from subsection (m) thereof the reference to “Newco” and inserting
“GenPar” in lieu thereof;

     (c) deleting from subsection (n) thereof the references to “GenPar” and “Assignment of
LP Interest” and inserting “Newco” and “Assignment of LP Option Interest,” respectively, in
lieu thereof.

     15. Section 5.2, Conditions to Obligations of the Seller and Kupfer. Section 5.2 of
the Purchase Agreement is hereby amended by:

     (a) deleting from subsection (e) thereof the reference to “Newco” and inserting
“GenPar” in lieu thereof;

     (b) deleting from subsection (f) thereof the references to “GenPar” and “Assignment of
LP Interest” and inserting “Newco” and “Assignment of LP Option Interest,” respectively, in
lieu thereof.

     16. Section 7.1, Termination. Section 7.1 of the Purchase Agreement is hereby amended
by deleting each reference to the date “January 31, 2006” and inserting “July 31, 2006” in lieu
thereof.

     17. Section 7.2, Notices. Section 7.2 of the Purchase Agreement is hereby amended by
deleting the reference to “Vsource, Inc.” and inserting “Tri-Isthmus Group, Inc.” in lieu thereof.

     18. Section 7.13, Usage. Section 7.13 of the Purchase Agreement is hereby amended by
inserting the following sentence at the end thereof: “Any reference in this Agreement to the
preamble or recitals hereto will, to the extent the context requires, include the preamble or
recitals, as the case may be, of any amendment hereto.”

     19. Section 7.14, Certain Definitions. The table of defined terms set forth in
Section 7.14(f) of the Purchase Agreement is hereby amended by:

5

 

     (a) deleting the definitions for “Assignment of LP Interest,” “LP Purchase Price,”
“Series B Shares” and “VSCE” therefrom; and

     (b) for each defined term listed in the table set forth below, either (i) correcting
the section reference in such table if such defined term is already listed in such table; or
(ii) inserting into such table a new row for each such defined term that is not already
listed in such table:

	 	 	 
	Defined Term	 	Section
	Assignment of LP Initial Interest
	 	5.1(n)
	Assignment of LP Option Interest
	 	5.1(n)
	Bill of Sale
	 	1.4(g)
	Closing
	 	1.2(b)
	Closing Date
	 	1.2(b)
	Elite Assets
	 	1.4(g)
	First Amendment
	 	Preamble thereto
	First Amendment Date
	 	Preamble to the First Amendment
	Initial Closing
	 	1.2(a)
	Initial LP Agreement
	 	1.4(c)
	Litigated Accounts Receivable
	 	2.9
	LP Initial Interest
	 	Recitals
	LP Option Interest
	 	Recitals
	LP Initial Purchase Price
	 	1.3(b)(i)
	LP Purchase Price
	 	1.3(b)(ii)
	Non-Litigated Accounts Receivable
	 	2.9
	Partnership Agreement
	 	5.1(j)
	Registration Rights Agreement
	 	5.1(l)
	Series B Initial Shares
	 	1.3(g)
	Series B Option Shares
	 	1.3(h)
	TISG
	 	1.2(a)

     20. Exhibit F, Form of Assignment of LP Interest. Exhibit F to the Purchase Agreement
is hereby deleted in its entirety and the Exhibit F attached hereto inserted in lieu thereof.

     21. Schedules. The Schedules to the Purchase Agreement are hereby deleted in their
entirety and the Schedules attached hereto inserted in lieu thereof.

ARTICLE II

Representations and Warranties; Closing Conditions; Ratification

     1. Representations and Warranties of the Sellers. The Seller and Kupfer, jointly and
severally, represent and warrant to the Buyer that: (a) all representations and warranties of the
Seller and Kupfer contained in the Purchase Agreement are true and correct in all respects at and
as of the First Amendment Date, without regard to any supplemental disclosure provided pursuant to
Section 4.3, with the same effect as though such representations and warranties were made
at and as

6

 

of the First Amendment Date (rather than as of the Effective Date as provided in the first
paragraph of Article II); (b) the execution, delivery and performance by the Seller and
Kupfer of this First Amendment has been duly authorized by all necessary action, corporate or
otherwise, on the part of the Seller and Kupfer, this First Amendment has been duly executed and
delivered by the Seller and Kupfer and this First Amendment is a legal, valid and binding agreement
of the Seller and Kupfer, enforceable against the Seller and Kupfer in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent
conveyance or similar laws affecting the enforcement of creditors’ rights generally and subject to
general principles of equity (regardless of whether enforcement is sought in a proceeding at law or
in equity); and (c) no event has occurred that with notice or the lapse of time or both would allow
the Seller or Kupfer to terminate the Purchase Agreement pursuant to Section 7.1.

     2. Representations and Warranties of the Buyer. The Buyers represent and warrant to
the Seller and Kupfer that: (a) all representations and warranties of the Buyers contained in the
Purchase Agreement are true and correct in all respects at and as of the First Amendment Date with
the same effect as though such representations and warranties were made at and as of the First
Amendment Date (rather than as of the Effective Date as provided in the first paragraph of
Article III); (b) the execution, delivery and performance by each Buyer of this First
Amendment has been duly authorized by all necessary action, corporate or otherwise, on the part of
such Buyer, this First Amendment has been duly executed and delivered by each Buyer and this First
Amendment is a legal, valid and binding agreement of each Buyer enforceable against such Buyer in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights
generally and subject to general principles of equity (regardless of whether enforcement is sought
in a proceeding at law or in equity); and (c) no event has occurred that with notice or the lapse
of time or both would allow the Buyers to terminate the Purchase Agreement pursuant to Section
7.1.

     3. Closing Conditions. Except as expressly set forth herein, and solely with respect
to the Initial Closing, each party hereby waives all closing conditions under the Purchase
Agreement set forth in Article V.

     4. Ratification and Reaffirmation. The terms and provisions set forth in this First
Amendment modify and supersede all inconsistent terms and provisions set forth in the Purchase
Agreement or in any other Purchase Document, and, except as expressly modified and superseded by
this First Amendment, the terms and provisions of the Purchase Agreement and all other Purchase
Documents are ratified and confirmed in all respects and will continue in full force and effect.
The parties hereto agree that the Purchase Agreement, as amended hereby, and the other Purchase
Documents continue to be legal, valid, binding and enforceable in accordance with their respective
terms.

ARTICLE III

Miscellaneous

     1. No Waiver. Except as set forth in Section 3 of Article II of this First Amendment,
nothing contained herein will be construed as a waiver by any party of any covenant or provision

7

 

of the Purchase Agreement or any other Purchase Document, and any party’s failure at any time
or times hereafter to require strict performance by any other party of any provision thereof will
not waive, affect or diminish any right of such party to thereafter demand strict compliance
therewith.

     2. Survival of Representations and Warranties. All representations and warranties
made in the Purchase Agreement or any other Purchase Document, including, without limitation, any
document furnished in connection with this First Amendment, will survive the execution and delivery
of this First Amendment and the other Purchase Documents, and no investigation by any party will
affect such representations and warranties or the right of such party to rely upon them.

     3. Counterparts. This First Amendment may be executed in one or more counterparts
(including by facsimile or portable document format (.pdf)) for the convenience of the parties
hereto, each of which will be deemed an original, but all of which together will constitute one and
the same instrument.

     4. Interpretation. The article and section headings contained in this First Amendment
are solely for the purpose of reference, are not part of the agreement of the parties and will not
in any way affect the meaning or interpretation of this First Amendment or the Purchase Agreement.

     5. GOVERNING LAW. THIS FIRST AMENDMENT WILL BE GOVERNED BY AND CONSTRUED AND
INTERPRETED IN ACCORDANCE WITH THE SUBSTANTIVE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT
TO ANY CONFLICTS OF LAW RULE OR PRINCIPLE THAT MIGHT RESULT IN THE APPLICATION OF THE LAWS OF
ANOTHER JURISDICTION.

     6. Drafting. The language in all parts of this First Amendment will be interpreted,
in all cases, according to its fair meaning and not for or against any party hereto. Each party
acknowledges that it and its legal counsel have reviewed and revised this First Amendment and that
the normal rule of construction to the effect that any ambiguities are to be resolved against the
drafting party will not be employed in the interpretation of this First Amendment.

     7. Usage. Whenever the plural form of a word is used in this First Amendment, it will
include the singular form of that word. Whenever the singular form of a word is used in this First
Amendment, it will include the plural form of that word. The term “or” will not be interpreted as
excluding any of the items described. The term “include” or any derivative of such term does not
mean that the items following such term are the only types of such items.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

8

 

     IN WITNESS WHEREOF, the parties hereto have executed this First Amendment to be effective as
of the First Amendment Date.

	 	 	 	 	 
	 	 	THE BUYERS:
	 
	 	 	 	 
	 	 	DEL MAR GENPAR, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:
	 	David Hirschhorn
	 

	 	Title:
	 	President and CEO
	 
	 	 	 	 
	 	 	DEL MAR ACQUISITION, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:
	 	David Hirschhorn
	 

	 	Title:
	 	President and CEO
	 
	 	 	 	 
	 	 	THE SELLER:
	 
	 	 	 	 
	 	 	SURGICAL VENTURES, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:
	 	David M. Kupfer, M.D.
	 

	 	Title:
	 	President
	 
	 	 	 	 
	 	 	KUPFER:
	 
	 	 	 	 
	 	 	 
	 	 	David M. Kupfer, M.D.

[Signature Page to First Amendment]

 

 

EXHIBIT F

FORM OF ASSIGNMENT OF LP [INITIAL][OPTION] INTEREST

     This Assignment of LP [Initial][Option] Interest (this “Assignment”) is made and
entered into as of                           , 2006, by and between Surgical Ventures, Inc., a California
corporation (“Assignor”), and Del Mar Acquisition, Inc., a Nevada corporation
(“Assignee”), in connection with that certain Partnership Interest Purchase Agreement dated
as of December 2, 2005 (as amended, the “Purchase Agreement”), by and among Del Mar GenPar,
Inc., a Nevada corporation; Assignee; Assignor; and David M. Kupfer, M.D., an individual residing
in the State of California. Capitalized terms used herein that are not otherwise defined have the
meanings ascribed to such terms in the Purchase Agreement.

W I T N E S S E T H:

     WHEREAS, Assignor is the owner of the LP [Initial][Option] Interest;

     WHEREAS, pursuant to the Purchase Agreement, Assignor has agreed to sell, transfer and convey
to Assignee, and Assignee has agreed to acquire from Assignor, the LP [Initial][Option] Interest;

     WHEREAS, in connection with such sale, transfer and conveyance, Assignor desires to assign the
LP [Initial][Option] Interest to Assignee, and Assignee desires to accept such assignment, pursuant
to the terms and provisions provided herein;

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and
agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties agree as follows:

     1. Assignor assigns, transfers and conveys to Assignee the LP [Initial][Option] Interest,
including all of Assignor’s rights and interests as an equityholder of the Partnership allocable or
attributable to the LP [Initial][Option] Interest and its proportionate right, title and interest
in and to the business, properties and assets of the Partnership and to the capital, distributions,
profits and losses of the Partnership or its successors, allocable or attributable to the LP
[Initial][Option] Interest, an equityholder of the Partnership.

     2. This Assignment and the covenants, obligations, undertakings, rights and benefits hereof
shall be binding upon, and shall inure to the benefit of, the respective parties hereto and their
respective successors and assigns.

     3. This Assignment may be executed in one or more counterparts (including by facsimile or
portable document format (.pdf)) for the convenience of the parties hereto, each of which will be
deemed an original, but all of which together will constitute one and the same instrument.

1

 

     4. Each party agrees to execute any and all documents and to perform such other acts as the
other party may reasonably request to further the purposes of this Assignment and the transactions
contemplated hereby.

     5. The recitals set forth in this Assignment are hereby incorporated into and made a part of
this Assignment for all purposes.

     6. THIS ASSIGNMENT WILL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE
SUBSTANTIVE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO ANY CONFLICTS OF LAW RULE OR
PRINCIPLE THAT MIGHT RESULT IN THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

2

 

     EXECUTED and DELIVERED to be effective as of the date first written above.

	 	 	 	 	 
	 	 	ASSIGNOR:
	 
	 	 	 	 
	 	 	SURGICAL VENTURES, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:
	 	David M. Kupfer, M.D.
	 

	 	Title:
	 	President
	 
	 	 	 	 
	 	 	ASSIGNEE:
	 
	 	 	 	 
	 	 	DEL MAR ACQUISITION, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:
	 	David Hirschhorn
	 

	 	Title:
	 	President and CEO

[Signature
Page to Assignment of LP [Initial] [Option] Interest]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]